Impairment of Th cell response in Card9 knockout mice with cutaneous mucormycosis caused by Rhizopus arrhizus.
Clicks: 424
ID: 4873
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
71.6
/100
424 views
312 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #1 of 13 articles by views in Experimental dermatology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Card9 is a signaling adaptor protein in the downstream of many innate pattern recognition receptors(PRRs) and exerts a significant role in antifungal immunity. To date, Card9 deficiency has been reported to be related to increased susceptibility to many fungal infections. In this study, we established mucormycosis murine model of Rhizopus arrhizus (R. arrhizus) using wild-type(WT) mice and Card9 knockout (Card9 ) mice to investigate the antifungal effect of Card9 against R. arrhizus infection. Card9 mice were more susceptible to R. arrhizus infection than WT mice, which could be related to the impaired NF-κB pathway activation, local cytokine production and Th cell responses in Card9 mice.
| Reference Key |
sun2019impairmentexperimental
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Sun, Lingyue;Wan, Zhe;Li, Ruoyu;Yu, Jin; |
| Journal | Experimental dermatology |
| Year | 2019 |
| DOI |
10.1111/exd.14020
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.